ON-TARGETplus Human ARL2BP siRNA

Protocol tips

Upstream tips	Protocol tips	Downstream tips
	Cells were grown in six-well culture dishes to 70–90% confluence. Plasmids (2 µg of pcDNA3.1 or pcDNA3.1 carrying indicated inserts and Mito-GFP; 2∶1 ratio) were co-transfected using LipofectAMINE and Plus reagents (Invitrogen) according to the manufacturer's instructions. siRNAs (25 nM) were transfected into HeLa cells using Dharmafect transfection reagent #1 (Dharmacon, Lafayette, CO) following the company's instructions. For some experiments, transfections were performed sequentially first with plasmid DNA followed 5 hours later by transfection of the ARL2 siRNA, to minimize cell toxicity evident from co-transfections. We consistently observed at least 70% transfection efficiency, using expression of fluorescence-tagged proteins to score

Protocol tips

Cells were grown in six-well culture dishes to 70–90% confluence. Plasmids (2 µg of pcDNA3.1 or pcDNA3.1 carrying indicated inserts and Mito-GFP; 2∶1 ratio) were co-transfected using LipofectAMINE and Plus reagents (Invitrogen) according to the manufacturer's instructions. siRNAs (25 nM) were transfected into HeLa cells using Dharmafect transfection reagent #1 (Dharmacon, Lafayette, CO) following the company's instructions. For some experiments, transfections were performed sequentially first with plasmid DNA followed 5 hours later by transfection of the ARL2 siRNA, to minimize cell toxicity evident from co-transfections. We consistently observed at least 70% transfection efficiency, using expression of fluorescence-tagged proteins to score

Publication protocol

Cells were grown in six-well culture dishes to 70–90% confluence. Plasmids (2 µg of pcDNA3.1 or pcDNA3.1 carrying indicated inserts and Mito-GFP; 2∶1 ratio) were co-transfected using LipofectAMINE and Plus reagents (Invitrogen) according to the manufacturer's instructions. siRNAs (25 nM) were transfected into HeLa cells using Dharmafect transfection reagent #1 (Dharmacon, Lafayette, CO) following the company's instructions. For some experiments, transfections were performed sequentially first with plasmid DNA followed 5 hours later by transfection of the ARL2 siRNA, to minimize cell toxicity evident from co-transfections. We consistently observed at least 70% transfection efficiency, using expression of fluorescence-tagged proteins to score

Full paper   Login or join for free to view the full paper.

Reviews

Discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing siRNA / miRNA gene silencing Human - HeLa BART/ARL2BP using ON-TARGETplus Human ARL2BP siRNA from Horizon Discovery Ltd..

Manufacturer protocol

Download the product protocol from Horizon Discovery Ltd. for ON-TARGETplus Human ARL2BP siRNA below.

Download manufacturer protocol

Videos

Check out videos that might be relevant for performing siRNA / miRNA gene silencing Human - HeLa BART/ARL2BP using ON-TARGETplus Human ARL2BP siRNA from Horizon Discovery Ltd.. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.